| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1020493202 |
| P356 | DOI | 10.1186/BCR1646 |
| P932 | PMC publication ID | 1851376 |
| P698 | PubMed publication ID | 17257427 |
| P5875 | ResearchGate publication ID | 6547673 |
| P50 | author | Barbara Gilchrest | Q93373562 |
| P2093 | author name string | Mark S Eller | |
| Kenneth H Cowan | |||
| Mina Yaar | |||
| Izabela Panova | |||
| John Kubera | |||
| Lee Hng Wee | |||
| P2860 | cites work | ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway | Q22253899 |
| Sequencing of chemotherapy and radiation therapy for early breast cancer | Q24243984 | ||
| Addition of drug/s to a chemotherapy regimen for metastatic breast cancer | Q24245443 | ||
| Amyloid beta binds trimers as well as monomers of the 75-kDa neurotrophin receptor and activates receptor signaling | Q24292067 | ||
| Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a) | Q24293520 | ||
| Activation of the ATM kinase by ionizing radiation and phosphorylation of p53 | Q24311891 | ||
| POT1 and TRF2 cooperate to maintain telomeric integrity | Q24338505 | ||
| A biomarker that identifies senescent human cells in culture and in aging skin in vivo | Q24562644 | ||
| Enhancement of DNA repair in human skin cells by thymidine dinucleotides: evidence for a p53-mediated mammalian SOS response | Q24646197 | ||
| The telomeric protein TRF2 binds the ATM kinase and can inhibit the ATM-dependent DNA damage response | Q24799005 | ||
| WAF1, a potential mediator of p53 tumor suppression | Q27861121 | ||
| The Werner syndrome helicase and exonuclease cooperate to resolve telomeric D loops in a manner regulated by TRF1 and TRF2 | Q28116237 | ||
| Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139 | Q28139691 | ||
| ATM phosphorylates histone H2AX in response to DNA double-strand breaks | Q28188651 | ||
| DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation | Q28206029 | ||
| Multidrug resistance in cancer: role of ATP-dependent transporters | Q28208049 | ||
| Tumor suppressor p53 is a direct transcriptional activator of the human bax gene | Q28306186 | ||
| Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation | Q28344288 | ||
| p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2 | Q28609749 | ||
| Enhanced phosphorylation of p53 by ATM in response to DNA damage | Q28609838 | ||
| A DNA damage checkpoint response in telomere-initiated senescence | Q29615919 | ||
| Cancer statistics, 2005 | Q29617572 | ||
| Positional cloning of the Werner's syndrome gene | Q29618393 | ||
| Cell cycle localization, dimerization, and binding domain architecture of the telomere protein cPot1. | Q31048028 | ||
| Stimulation of melanogenesis by DNA oligonucleotides: effect of size, sequence and 5' phosphorylation | Q31871227 | ||
| Receptor-mediated endocytosis of phosphodiester oligonucleotides in the HepG2 cell line: evidence for non-conventional intracellular trafficking | Q33601089 | ||
| TRF2 recruits the Werner syndrome (WRN) exonuclease for processing of telomeric DNA. | Q34288672 | ||
| Evidence that exposure of the telomere 3' overhang sequence induces senescence | Q34470102 | ||
| Platinum compounds in the treatment of advanced breast cancer | Q34567703 | ||
| Smart drugs: tyrosine kinase inhibitors in cancer therapy | Q34710595 | ||
| Radiation therapy planning with photons and protons for early and advanced breast cancer: an overview | Q35005607 | ||
| A role for WRN in telomere-based DNA damage responses | Q35062281 | ||
| DNA damage induces phosphorylation of the amino terminus of p53 | Q35199554 | ||
| Metastatic breast cancer: overview of treatment | Q35576793 | ||
| DNA damage tumor suppressor genes and genomic instability | Q35755997 | ||
| Experimental elongation of telomeres extends the lifespan of immortal x normal cell hybrids | Q35847527 | ||
| Human cell senescence as a DNA damage response. | Q35989854 | ||
| Therapeutic observations in MCF-7 aromatase xenografts. | Q36035298 | ||
| The tale of the telomere: implications for prevention and treatment of skin cancers | Q36346181 | ||
| intraoperative radiation therapy part 2. Clinical results | Q36543402 | ||
| Drug resistance, predictive markers and pharmacogenomics in colorectal cancer | Q36594315 | ||
| Systemic treatment of breast cancer. Two decades of progress | Q36598614 | ||
| Optimal sequence of hormonotherapy in advanced breast cancer | Q36599847 | ||
| Characteristics of oligonucleotide uptake in human keratinocyte cultures | Q36754538 | ||
| Topical DNA oligonucleotide therapy reduces UV-induced mutations and photocarcinogenesis in hairless mice. | Q37095361 | ||
| Binding of beta-amyloid to the p75 neurotrophin receptor induces apoptosis. A possible mechanism for Alzheimer's disease. | Q37374362 | ||
| Induction of apoptosis by telomere 3' overhang-specific DNA. | Q38288992 | ||
| Characterisation of membrane oligonucleotide-binding proteins and oligonucleotide uptake in keratinocytes | Q38324853 | ||
| Signaling pathway requirements for induction of senescence by telomere homolog oligonucleotides | Q38334543 | ||
| Exploration of replicative senescence-associated genes in human dermal fibroblasts by cDNA microarray technology | Q38335351 | ||
| Induction of a p95/Nbs1-mediated S phase checkpoint by telomere 3' overhang specific DNA. | Q38358265 | ||
| Different telomere damage signaling pathways in human and mouse cells | Q39647901 | ||
| Features that determine telomere homolog oligonucleotide-induced therapeutic DNA damage-like responses in cancer cells | Q40203284 | ||
| DNA damage induces transcriptional activation of p73 by removing C-EBP repression on E2F1 | Q40240911 | ||
| Role of chemotherapy resistance genes in outcome of neuroblastoma | Q40293489 | ||
| Nuclease resistance of telomere-like oligonucleotides monitored in live cells by fluorescence anisotropy imaging | Q40311165 | ||
| Cellular and gene expression responses involved in the rapid growth inhibition of human cancer cells by RNA interference-mediated depletion of telomerase RNA. | Q40435095 | ||
| Telomere-based DNA damage responses: a new approach to melanoma | Q40521591 | ||
| Effects of the multidrug transporter P-glycoprotein on cellular responses to ionizing radiation | Q40877882 | ||
| Phase II study of cis-dichlorodiammineplatinum(II) in advanced breast cancer | Q40887308 | ||
| Negative regulation of MDR1 promoter activity in MCF-7, but not in multidrug resistant MCF-7/Adr, cells by cross-coupled NF-kappa B/p65 and c-Fos transcription factors and their interaction with the CAAT region | Q40971862 | ||
| Human MDR 1 protein overexpression delays the apoptotic cascade in Chinese hamster ovary fibroblasts. | Q41091588 | ||
| Tumor necrosis factor-alpha-induced apoptosis in a human keratinocyte cell line (HaCaT) is counteracted by transforming growth factor-alpha | Q41155049 | ||
| Chemosensitivity of human MCF-7 breast cancer cells to diastereoisomeric diaqua(1,2-diphenylethylenediamine) platinum(II) sulfates and specific platinum accumulation | Q41645742 | ||
| Failure to phosphorylate the retinoblastoma gene product in senescent human fibroblasts | Q41725165 | ||
| Meeting highlights: International consensus panel on the treatment of primary breast cancer | Q43937198 | ||
| Tumour resistance to cisplatin: a modelling approach. | Q45268931 | ||
| A novel form of Epstein-Barr virus latency in normal B cells in vivo | Q45789413 | ||
| Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia | Q46443538 | ||
| Thymidine dinucleotides induce S phase cell cycle arrest in addition to increased melanogenesis in human melanocytes | Q46718886 | ||
| Relation between cytochrome P450IA1 expression and estrogen receptor content of human breast cancer cells | Q46865726 | ||
| Telomere 3' overhang-specific DNA oligonucleotides induce autophagy in malignant glioma cells | Q48193623 | ||
| T-oligos augment UV-induced protective responses in human skin. | Q53608224 | ||
| Rapid inhibition of cancer cell growth induced by lentiviral delivery and expression of mutant-template telomerase RNA and anti-telomerase short-interfering RNA. | Q53851296 | ||
| Mesenchymal Stem Cells: Potential Precursors for Tumor Stroma and Targeted-Delivery Vehicles for Anticancer Agents | Q58828469 | ||
| Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents | Q64379193 | ||
| Histone H2A variant synthesis in aging human diploid cells | Q68202576 | ||
| A rapid in vitro screening system for the identification and evaluation of anticancer drugs | Q69392637 | ||
| An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene | Q69918341 | ||
| Targeting the kinesin Eg5 to monitor siRNA transfection in mammalian cells | Q78721630 | ||
| Concurrent radiotherapy and taxane chemotherapy in patients with locoregional recurrence of breast cancer. A retrospective analysis | Q79168862 | ||
| The DNA damage machinery and homologous recombination pathway act consecutively to protect human telomeres | Q79365400 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast carcinoma | Q18555947 |
| P304 | page(s) | R13 | |
| P577 | publication date | 2007-01-01 | |
| P1433 | published in | Breast Cancer Research | Q2208481 |
| P1476 | title | Telomeric DNA induces apoptosis and senescence of human breast carcinoma cells | |
| P478 | volume | 9 |
| Q38819605 | Beyond Telomerase: Telomere Instability as a Novel Target for Cancer Therapy |
| Q35600151 | Bioengineering embryonic stem cell microenvironments for the study of breast cancer |
| Q37146556 | Clinical implications of antitelomeric drugs with respect to the nontelomeric functions of telomerase in cancer |
| Q47428247 | Cytotoxicity of guanine-based degradation products contributes to the antiproliferative activity of guanine-rich oligonucleotides |
| Q37277677 | Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer |
| Q37139643 | Enhanced cytotoxicity from deoxyguanosine-enriched T-oligo in prostate cancer cells. |
| Q39434311 | Epithelial cell senescence: an adaptive response to pre-carcinogenic stresses? |
| Q42105603 | Inhibition of melanoma angiogenesis by telomere homolog oligonucleotides |
| Q37093551 | Mechanism of DNA damage responses induced by exposure to an oligonucleotide homologous to the telomere overhang in melanoma |
| Q35652897 | Mechanism of T-oligo-induced cell cycle arrest in Mia-PaCa pancreatic cancer cells |
| Q39095019 | Non-small cell lung cancer is susceptible to induction of DNA damage responses and inhibition of angiogenesis by telomere overhang oligonucleotides |
| Q39037222 | Novel delivery system for T-oligo using a nanocomplex formed with an alpha helical peptide for melanoma therapy |
| Q58696640 | Oligonucleotides Targeting Telomeres and Telomerase in Cancer |
| Q39445490 | Photodynamic therapy of Pheophorbide a inhibits the proliferation of human breast tumour via both caspase-dependent and -independent apoptotic pathways in in vitro and in vivo models. |
| Q26744221 | Positive and negative effects of cellular senescence during female reproductive aging and pregnancy |
| Q34989021 | Radiosensitization of mammary carcinoma cells by telomere homolog oligonucleotide pretreatment. |
| Q38305253 | Star-shaped tetraspermine enhances cellular uptake and cytotoxicity of T-oligo in prostate cancer cells |
| Q89597527 | Structural Features of Nucleoprotein CST/Shelterin Complex Involved in the Telomere Maintenance and Its Association with Disease Mutations |
| Q36643420 | Suppressive oligodeoxynucleotides synergistically enhance antiproliferative effects of anticancer drugs in A549 human lung cancer cells |
| Q35121429 | T-oligo as an anticancer agent in colorectal cancer |
| Q35048659 | T-oligos inhibit growth and induce apoptosis in human ovarian cancer cells |
| Q39379394 | Telomerase and drug resistance in cancer. |
| Q35784732 | Telomere Fragment Induced Amnion Cell Senescence: A Contributor to Parturition? |
| Q26744808 | Telomere and Telomerase Therapeutics in Cancer |
| Q33924555 | Telomere homolog oligonucleotides induce apoptosis in malignant but not in normal lymphoid cells: mechanism and therapeutic potential |
| Q36862798 | Telomere-homologous G-rich oligonucleotides sensitize human ovarian cancer cells to TRAIL-induced growth inhibition and apoptosis |
| Q37579017 | Telomere-mediated effects on melanogenesis and skin aging |
| Q38348975 | Telomeric DNA induces p53-dependent reactive oxygen species and protects against oxidative damage |
| Q36579806 | Topical thymidine dinucleotide treatment reduces development of ultraviolet-induced basal cell carcinoma in Ptch-1+/- mice |
| Q38288984 | Treating Cancer by Targeting Telomeres and Telomerase |
| Q38310060 | hnRNP C1/C2 and Pur-beta proteins mediate induction of senescence by oligonucleotides homologous to the telomere overhang |
Search more.